We founded SUMS to galvanize the private investment community & improve the fluidity of capital to early-stage companies. To do this, we provide the tools and information required to solve many of the challenges faced in early-stage investing.

Co-founder and Chairman of Allumiqs (Formerly Proteoform Scientific).

BioNova leads, accelerates, and advocates for Nova Scotia’s growing health and life sciences sector.

As Chief Executive Officer and Co-founder I led the financing and sales efforts resulting in the company developing and commercializing a disruptive technology that received FDA 510(k) clearance and is now used by the world's leading cancer centers in 14 countries.

CEO of Adaptiiv Medical Technologies Inc. Executive Director, IR Scientific Inc. Executive Director, Proteoform Scientific Inc.

Company Co-founder responsible for intellectual property and product vision, operations and capital financing. Responsible for the recruitment and retention of core technology team. I work directly with the technology team to develop and execute product roadmap. Recognized inventor on the patent filings on Method and System for Content Aggregation Utilizing Contextual Indexing. Lead in the capital raise and financing of Oris4.

Coemergence is a software company that develops and sells ACIS®. ACIS® is the only complete decision support making platform in the market today and is recognized as one of the world's leading tools to gather, organize and share massive amounts of information. This gives executives an effective strategic analysis and decision making platform.

Buell Group is a management consulting firm that specializes in developing and executing growth plans for technology companies.